Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label (Part A) and a Double-Blind, Randomized, Placebo Controlled (Part B) Study, With an Open-Label Extension, of Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata

NCT02553330 is registered in ClinicalTrials.gov with Incyte Corporation as lead sponsor.

NCT NCT02553330
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02553330 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label (Part A) and a Double-Blind, Randomized, Placebo Controlled (Part B) Study, With an Open-Label Extension, of Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata
Lead sponsor
Incyte Corporation
Phase
Phase 2
Overall status
Terminated
Start date
November 18, 2015
Completion date
October 3, 2017
Enrollment
90 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

alopecia areata